Patents Archives - Page 6 of 63 - Spruson & Ferguson

9th Sep 2021

Possible upcoming amendments to Singapore Patents Act and Patents Rules – what you need to know

The Intellectual Property Office of Singapore (“IPOS”) conducted a public consultation which ended on 12 August 2021, to seek feedback on a proposed Intellectual Property (“IP”) (Amendment) Bill 2021...

The Intellectual Property Office of Singapore (“IPOS”) conducted a public consultation which ended on 12 August 2021, to seek...

2nd Sep 2021

Clinical Trial Roulette: patenting pharmaceuticals in Australia is now a game of chance

While the case of Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd1 (‘Mylan v Sun Pharma’) was decided a little over a year ago, some of the...

While the case of Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd1 (‘Mylan v Sun Pharma’) was...

26th Aug 2021

Dead or Alive: Statuses, Patent Expiries and Kind Codes – Part 3

I'm exploring statuses, patent expiries and kind codes in a three part series of articles. The first article on statuses can be found here, and the second article on...

I'm exploring statuses, patent expiries and kind codes in a three part series of articles. The first article on...

26th Aug 2021

The Australian Federal Court removes a pharmaceutical patent term extension because of the patentee’s own earlier registered goods

In Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, the Federal Court of Australia has determined that a pharmaceutical patent term extension (PTE) for a...

In Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, the Federal Court of Australia has...

24th Aug 2021

Practice note: what to do with medical use claims when employing the foreign route of prosecution in Singapore

Up until 1 January 2020, the Foreign Route was an available patent prosecution option of a Singapore application having a local or international filing date prior to 1 January...

Up until 1 January 2020, the Foreign Route was an available patent prosecution option of a Singapore application having...

18th Aug 2021

Patent term extensions in Australia: Can a “first regulatory approval” less than 5 years after the patent filing date be ignored?

Australia’s Federal Court Decision, Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, concerns a patent claiming two pharmaceutical substances having different first regulatory approval dates;...

Australia’s Federal Court Decision, Merck Sharp & Dohme Corp. v Sandoz Pty Ltd FCA 947, concerns a patent...

13th Aug 2021

Why cannot our creations also create

Thaler v Commissioner of Patents FCA 879 The Australian Federal Court has remarkably overturned an earlier hearing decision by the Australian Patent Office concluding that an Artificial Intelligence (AI)...

Thaler v Commissioner of Patents FCA 879 The Australian Federal Court has remarkably overturned an earlier hearing decision by...

4th Aug 2021

FemTech in Australia – What’s going on Down Under?

FemTech is surging around the world with new start-ups and technology entering the marketplace every day, but what’s going on Down Under? Need for FemTech As of June 2019, just over...

FemTech is surging around the world with new start-ups and technology entering the marketplace every day, but what’s going...

3rd Aug 2021

Question & Answer with a patent attorney

Part 2: Patent Claims We continue our discussion of some common questions encountered in patent law, turning now to the topic of patent claims. You can view Part 1: Prior...

Part 2: Patent Claims We continue our discussion of some common questions encountered in patent law, turning now to the...

2nd Aug 2021

Australia’s intelligent approach to artificial intelligence inventions

An Australian court has provided a clear signal that inventions derived from machine learning activities can be subject to valid patent applications, provided they satisfy the regular indicia of...

An Australian court has provided a clear signal that inventions derived from machine learning activities can be subject to...

29th Jul 2021

China’s 2021-2025 Five-Year Plan – an outlook to China’s planned future for IP

China’s economic development is following the initiatives of the Central government in the form of five-year projects. IP owners are encouraged to check and further analyse the recent draft...

China’s economic development is following the initiatives of the Central government in the form of five-year projects. IP owners...

23rd Jul 2021

Instructions not received – how hard should we follow up?

The Australian Patent system is relatively forgiving in terms of missed deadlines. The Patents Act provides extensions of time for complying with most deadlines, provided that a genuine error...

The Australian Patent system is relatively forgiving in terms of missed deadlines. The Patents Act provides extensions of time...